Xybion's Pristima Preclinical Software suite has been selected for early-stage drug discovery pathology data management by a top-5 biotech firm.
Pristima suite is the fully integrated preclinical and vivarium management solution that connects to enterprise quality & compliance management processes.
Xybion Preclinical Solutions vice president Carlos Frade said for both early discovery safety assessment and safety pharmacology, Pristima provides the simple, easy-to-use data management tool sets and features that cater to the dynamic approaches in early discovery.
"The Pristima Total Preclinical Solution adds value because it facilitates the process of drug development from formulation through FDA submissions," Frade added.
Xybion CEO Pradip Banerjee said the company's relationship with the bitech firm shows the global capabilities with respect to interconnected preclinical data management and validates its ability to deliver valuable solutions on a global scale to life science companies.